• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,958.52 940.73
( 1.22%)
Global Indices
Nasdaq
49,922.52 603.26
(1.22%)
Dow Jones
7,387.39 107.17
(1.47%)
Hang Seng
59,594.47 309.55
(0.52%)
Nikkei 225
10,442.09 222.98
(2.18%)
Forex
USD-INR
95.09 0.27
(0.28%)
EUR-INR
111.34 0.19
(0.17%)
GBP-INR
128.90 0.20
(0.16%)
JPY-INR
0.61 0.00
(0.29%)

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
78871
INE0L4V01013
17.34
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
VILINBIO
299
68.4
EPS(TTM)
Face Value()
Div & Yield %
0.15
10
0
 

AAVAS Financiers standalone net profit rises 18.21% in the March 2026 quarter
May 06,2026
Net profit of AAVAS Financiers rose 18.21% to Rs 181.67 crore in the quarter ended March 2026 as against Rs 153.68 crore during the previous quarter ended March 2025. Sales rose 12.33% to Rs 714.68 crore in the quarter ended March 2026 as against Rs 636.21 crore during the previous quarter ended March 2025.

For the full year,net profit rose 14.07% to Rs 654.88 crore in the year ended March 2026 as against Rs 574.11 crore during the previous year ended March 2025. Sales rose 13.97% to Rs 2683.46 crore in the year ended March 2026 as against Rs 2354.51 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales714.68636.21 12 2683.462354.51 14
OPM %72.2073.32 -73.6775.29 -
PBDT242.72203.02 20 883.55769.04 15
PBT230.77193.23 19 840.44732.59 15
NP181.67153.68 18 654.88574.11 14